Analysts at the financial institution Handelsbanken are bemused that Ambu downgraded its guidance last year, since this move contrasts with announcements made by other contractors in the hospital sector, according to a stock exchange announcement from Handelsbanken on Monday.
On Thursday last week, Ambu downgraded its predicted guidance for the firm's organic growth and margin for earnings before interest and taxation for the staggered fiscal year 2020/2021 referring to the fact that the covid-19 pandemic is still affecting the number of operations being performed. This challenges the supply chain and causes delays.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP recommends nine new drugs, rejects one
Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.
WS Audiology still chewing over listing of online hearing company
The hearing giant is still mulling over the independent listing of Hear.com.
CEO at WSA: No clarity on EQT exit plans yet
The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.
Oticon: Covid-19 led to debates about product launches
The unpredictable world situation in the spring of 2020 meant that the timing of product launches was frequently discussed at Demant-owned Oticon, located in Denmark.
EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry
With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.
Medical Scientific Liaison Dermo aesthetic, IBSA 
Associate Director/Senior Manager, Global Regulatory Affairs Project Lead - Genmab 
Formulation Development Specialist – Product Lifecycle Management (PLM), Orifarm 
Senior QA Specialist - Vaccibody 
Employee of the regulatory department with knowledge of food safety and legislation within dietary supplements and medicines 
Associate Director, PV QA - Y-mAbs Therapeutics 
KLIFO is looking for a talented Medical Writer (DK, SE or DE) 
Principal Scientist, In Vivo Pharmacology 
Evaxion Biotech Careers 
Global Senior Medical Advisor – Neurology Pipeline Projects, Lundbeck 
Project Manager, Adcendo ApS 
Medical Director (diabetes and obesity) - Zealand Pharma 
A tech-savvy Project Manager Oncology (m/f/x) with a passion for communication and cross-functional collaboration - Daiichi-Sankyo 
Senior Clinical Research Specialist - Ambu